Skip to content

A study to evaluate the efficacy of Maharasnadi Kashaya and Kapikacchu Choorna with Shuddha Bala Taila Matra Bati in the management of Kampavata (Parkinsons Disease).

A randomized open labelled comparative clinical study to evaluate the efficacy of oral administration of Maharasnadi Kashaya and Kapikacchu Choorna with Shuddha Bala Taila Matra Basti in the management of Kampavata with special reference to Parkinsons Disease. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070428
Enrollment
30
Registered
2024-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease

Interventions

None listed

Sponsors

Dr Prekshna Gabriella Paul
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects presenting with the lakshanas of Kampavata like karapaadatale kampa(tremors), deha bhramana (whirling sensation), nidrabhanga(sleeplessness) and kshinamati (dementia). 2) Subjects presenting the clinical features of PD like tremors, rigidity, bradykinesia. 3) Subjects who have been freshly diagnosed with Idiopathic PD or less than 5 year history and those who are not on any medications for Parkinson’s disease. 4) Subjects irrespective of gender in between the age group 40 to 65 years. 5) Subjects who are indicated and fit for Matra basti. 6) Subjects willing to participate with written informed consent, which is conveyed in the language, which the subject can understand.

Exclusion criteria

Exclusion criteria: 1) Subjects with other varieties of Tremors like essential tremors, senile tremors. 2) Subjects who are on any medications for Parkinson’s disease. 3) Subjects diagnosed with uncontrolled systemic diseases like HTN and DM. 4) Subjects with history of Major head injury.

Design outcomes

Primary

MeasureTime frame
Significant decrease in symptoms of Parkinson’s Disease assessed based on MDS-UPDRS Scale.Timepoint: Before intervention- 0th day After intervention- 30th day Follow up- 45th day

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Prekshna Gabriella Paul

Sri Sri College of Ayurvedic Science and research

drgayathrig3@gmail.com9632468003

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026